Roger S. McIntyre, MD, FRCPC
Department of Psychiatry, University of Toronto, Toronto, Canada; Department of Pharmacology, University of Toronto, Toronto, Canada; Brain and Cognition Discovery Foundation, Toronto, Canada.
Article
A Post Hoc Analysis of the Effect of Weight on Efficacy in Depressed Patients Treated With Desvenlafaxine 50 mg/d and 100 mg/d
June 4, 2015
The authors of this article conducted a post hoc analysis of data from 8 short-term and 1 longer-term double-blind, placebo-controlled studies of patients with major depressive disorder treated with...
Article
An Analysis of Relapse Rates and Predictors of Relapse in 2 Randomized, Placebo-Controlled Trials of Desvenlafaxine for Major Depressive Disorder
February 26, 2015
In this article by McIntyre and colleagues, relapse rates and predictors of relapse were evaluated in 2 randomized, placebo-controlled trials of desvenlafaxine for major depressive disorder.
Article
Mixed Specifier for Bipolar Mania and Depression: Highlights of DSM-5 Changes and Implications for Diagnosis and Treatment in Primary Care
April 15, 2014
Unlike the DSM-IV-TR, the DSM-5 allows patients with subsyndromal mixed symptoms to receive a diagnostic specifier for mixed features. Read about these diagnostic changes for bipolar disorder and their...
